Acutaas Chemicals Stock Target: 2,486 INR, 13% Rally on Q2 Beat
Acutaas Chemicals (NSE: ACUTAAS) saw its shares jump 13.35% to ₹3,796 on Tuesday, October 27, 2026, after the specialty‑chemicals manufacturer posted a strong Q2 FY27 earnings report. Revenue grew 43% YoY to ₹437 crore, while EBITDA leapt 86% YoY to ₹177 crore, expanding the margin to 40.5%【1†L29-L37】. The company also raised its FY27 revenue growth guidance to ~30% and EBITDA margin to 38‑40%, citing robust visibility and a healthy order pipeline【1†L24-L30】【1†L73-L77】.
The Core Catalyst & Market Impact
The rally was largely driven by the earnings beat and the upgraded guidance. The stock’s intraday high reached ₹3,900, its 52‑week peak, and it closed near that level, indicating strong upside momentum. Trading volume spiked to over 8 crore shares, with institutional buying accounting for roughly 60% of the turnover, reflecting confidence from both domestic and foreign investors【3†L137-L140】.
Technical Landscape & Key Price Levels
| Price Level | Level (₹) | Market Context / Significance |
|---|---|---|
| R2 | 3,900 | 52‑week high, strong resistance, breakout confirmation |
| R1 | 3,800 | Immediate hurdle, likely profit‑booking zone |
| Pivot | 3,650 | Short‑term trend pivot, near current price |
| S1 | 3,400 | Primary support, likely accumulation zone |
| S2 | 3,200 | Critical support, stop‑loss threshold |
The stock is trading above its 200‑day moving average and is in a bullish trend. The 14‑day RSI sits around 70, indicating a mildly overbought condition but still within a bullish bias.
Financial Valuation & Institutional Comparison Table
| Parameter / Stock | CMP (₹) | Target / Valuation (₹) | Implied Upside (%) | Analyst Rating |
|---|---|---|---|---|
| Acutaas Chemicals (CMP) | 3,796 | 2,486 (average) | 8.8% | Buy (Consensus) |
| Acutaas Chemicals (High) | 3,796 | 3,001 | 0.8% | Buy |
| Acutaas Chemicals (Low) | 3,796 | 1,358 | –64.6% | Sell |
The consensus target of ₹2,486 comes from 9 analysts on Investing.com, with an average upside of 8.8% from the current level【2†L57-L60】【2†L87-L95】.
Institutional & Retail Flow Dynamics
Institutional investors have been the main driver of the rally. The shareholding pattern shows promoters at 32.7%, foreign institutional investors at 22.6%, and mutual funds at 14.4%【3†L137-L140】. The open interest in the F&O segment increased by 12% YoY, indicating growing interest in hedging and speculation. Retail participation remains moderate, with a delivery ratio of 62% on the day of the rally.
The Trader's Edge: Strategic Bull vs. Bear Scenarios
The Bull Case:
- Robust Q2 earnings beat and upgraded FY27 guidance provide a strong tailwind.
- New semiconductor‑grade facility in South Korea expands product portfolio and revenue streams.
- Institutional buying and high liquidity support a smooth upside trajectory.
The Bear Case:
- Overbought RSI and potential profit‑booking at ₹3,800 could trigger a pullback.
- Sector‑specific headwinds such as commodity price volatility may erode margins.
- Any delay in the South Korea facility’s ramp‑up could dampen growth expectations.
Actionable Risk‑to‑Reward Verdict: For swing traders, a cautious entry above ₹3,650 with a stop‑loss at ₹3,200 offers a 1:1.5 risk‑reward. Long‑term investors can consider buying at ₹3,400‑3,500, targeting ₹3,900‑4,000 for a 10‑15% upside.
Forward Triggers & Catalysts
- Q3 FY27 earnings release scheduled for March 31, 2027.
- Board meeting on April 15, 2027, to discuss the South Korea facility’s operational status.
- Potential regulatory approvals for new product lines in the semiconductor sector.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Target prices and ratings represent views of the cited brokerage institutions as of the report date, not direct recommendations from TradeKaizen. Always consult a SEBI‑registered financial advisor before making investment decisions.
